Fomento Economico Mexicano SAB de CV Sponsored ADR Class B FMX 深 沪
等待开盘 04-01 09:30:00 美东时间
111.06
+2.950
+2.73%
华盛通- 最 高111.26
- 今 开109.00
- 成交量 47.89万股
- 最 低 108.985
- 昨 收 108.11
- 总市值 385.38亿
- 52周最高 116.09
- 市盈率 静 31.35
- 换手率 0.14%
- 52周最低 79.4488
- 委 比 0.00%
- 总股本 3.47亿
- 历史最高 132.6988
- 量 比 1.17
- 振 幅 2.10%
- 历史最低 35.8364
- 每 手 1
- 风险率 7.99%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Fomento Económico Mexicano Announces New $300M Accelerated Share Repurchase Program; Expected To Be Completed Q2 2026
The total number of shares ultimately repurchased under the new ASR agreement will be based on the daily volume-weighted average price of the Company's ADSs during the term of the agreement, less a discount. The final
03-23 21:16
BRIEF-Femsa Completes Accelerated Share Repurchase Agreement, And Announces New Agreement
BRIEF-Femsa Completes Accelerated Share Repurchase Agreement, And Announces New Agreement Fomento Economico Mexicano SAB de CV FEMSAUBD.MX : FEMSA COMPLETES ACCELERATED SHARE REPURCHASE AGREEMENT, AND ANNOUNCES NEW AGREEMENT FOMENTO ECONOMICO MEXICANO SAB DE CV - TO REPURCHASE UP TO $300 MILLION OF
03-23 21:11
美股大行评级 | 小摩、瑞穗等下调阿里目标价最低至164美元；达登饭店、联邦快递、林肯教育服务、Planet Labs等获多家大行上调目标价
今日重点评级关注：瑞穗：维持RELMADA THERAPEUTICS"跑赢大市"评级，目标价从10美元升至19美元；奥本海默：维持Pelthos Therapeutics"跑赢大市"评级，目标价从60美元升至62美元
03-23 13:53
UBS Maintains Buy on Fomento Economico, Raises Price Target to $122
UBS analyst Rodrigo Alcantara maintains Fomento Economico (NYSE:FMX) with a Buy and raises the price target from $109 to $122.
03-20 22:35
'Mexico's Femsa Cuts Jobs After Bid to Become Fintech Powerhouse Fizzles' - Bloomberg
https://www.bloomberg.com/news/articles/2026-03-20/mexico-s-femsa-cuts-jobs-after-fintech-bid-fizzles
03-20 19:42
FEMSA Retains 19% Stake as BradyPLUS–Imperial Dade Merger Closes
Fomento Economico Mexicano ( ($FMX) ) has shared an announcement. On March 12, ...
03-12 20:59
美股大行评级 | 绩后暴跌超22%，MongoDB遭14家大行集团下调目标价；挪威邮轮、阿莎娜、Quantum Computing等也遭大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NRX Pharmaceuticals"买入"评级，目标价从40美元升至45美元；RBC Capital：维持NUVATION BIO"跑赢大市"评级，目标价从12美元升至13美元
03-04 10:22
Barclays Maintains Equal-Weight on Fomento Economico, Raises Price Target to $118
Barclays analyst Benjamin Theurer maintains Fomento Economico (NYSE:FMX) with a Equal-Weight and raises the price target from $116 to $118.
03-03 23:36
Fomento Economico Q4 Earnings Report: What Investors Need to Know
Fomento Economico (NYSE:FMX) announced its Q4 earnings on Wednesday, February 2...
02-25 21:08
Fomento Economico Q4 EPS $1.36 Misses $1.53 Estimate, Sales $12.023B Miss $12.440B Estimate
Fomento Economico (NYSE:FMX) reported quarterly earnings of $1.36 per share which missed the analyst consensus estimate of $1.53 by 11.11 percent. This is a 49.45 percent increase over earnings of $0.91 per share from
02-25 21:07
